Artificial intelligence and machine learning companies develop software, algorithms and computational platforms that analyse biological data, automate workflows and accelerate scientific discovery. These technologies are increasingly used across drug discovery, diagnostics, genomics and healthcare research.
This category includes companies working on:
Browse 243 UK AI and machine learning companies below.
Ultra-sensitive DNA detection platform
InvenireX is developing a nucleic acid detection platform that uses programmable DNA nanostructures captured within microfluidic chips, read by a proprietary AI-powered imaging system. The technology detects genetic markers at concentrations below the threshold of conventional methods such as PCR, with potential to…
AI-powered microbiome and phage therapy platform for gut disorders
GutSee Health is a biotechnology company developing precision microbiome therapies for gut disorders including irritable bowel syndrome and inflammatory bowel disease. Its AI discovery platform integrates multi-omics and microbiome data to identify molecular disease signatures and therapeutic targets. A parallel…
Targeting developmentally-silent oncogenic drivers for cancer therapy
Awen Oncology is a Welsh oncology biotechnology company developing first-in-class therapeutics that target cancer-specific proteins derived from developmental genes that are dormant in healthy adult tissue but aberrantly reactivated in tumour cells. The company's platform integrates high-throughput cell and molecular…
AI-powered cancer biomarker profiling from tissue images
Panakeia is an AI diagnostics company developing software that predicts molecular biomarker status directly from standard H&E-stained tissue images. Its CE-marked and UKCA-certified breast cancer product reports ER, PR, and HER2 status in minutes, reducing the need for conventional laboratory testing. The platform…
AI-driven enzyme discovery for sustainable industrial ingredients
Scindo is a UK biotechnology company developing an AI-powered enzyme discovery and engineering platform to produce bio-based alternatives to petroleum-derived industrial ingredients. The company combines machine learning with proprietary experimentally validated reaction datasets to discover and optimise enzymes…
In vivo nanoparticle screening for genetic medicine delivery
Ride Therapeutics is a joint University of Cambridge and Harvard spin-out developing nanoparticle delivery systems for mRNA and gene-editing medicines. Its Molecular Logistics platform engineers and screens large libraries of non-viral carriers in living systems, measuring tissue and cell-type targeting to train an…
Microbiome platform optimising hydroponic crop performance
Concert Bio is an agricultural biotechnology company developing microbial products to optimise crop performance in hydroponic greenhouses. Its platform combines the world's largest hydroponic microbiome database with machine learning to identify beneficial microbes tailored for soilless growing systems. The company's…
AI-powered ultrasound analysis software for endometriosis detection
Revela is a medical software company developing machine learning tools to assist in the diagnosis of endometriosis via analysis of ultrasound scans. The software automatically identifies subtle imaging signs associated with endometriosis and returns a structured report to the reviewing clinician, targeting earlier…
AI platform for in silico antibody discovery
Antiverse is a Cardiff-based company using machine learning to identify diverse and rare antibody candidates from next-generation sequencing data of naïve and immune repertoires. Its AI-augmented discovery platform analyses NGS data in silico to shortlist effective and developable antibodies, claiming a tenfold…
Biopesticides, insect lures and smart traps for sustainable pest management
Razbio is a Welsh biotech company developing sustainable pest management solutions for agriculture and public health. Its product portfolio spans fungal biopesticides, AI-identified insect lures and repellents, and automated AI-equipped smart traps for field pest monitoring. Validated products include a lure for…
Engineered bacteriophages for precision antimicrobial discovery
BioPhoundry is an engineering biology company developing bacteriophage-based technologies for precision antimicrobial research. Its Phax platform combines machine learning, synthetic biology and cell-free production to accelerate phage discovery and engineering. The company aims to generate tailored phages for…
AI platform predicting patient response to cancer immunotherapy
Curenetics is a medical technology company developing AI-powered tools to predict cancer patient responses to immunotherapy before treatment begins. Its platform integrates multi-omic genomic data, imaging profiles and clinical information to identify biomarkers of treatment efficacy and toxicity. The company also…
Blood-based microRNA test for multi-cancer early detection
Xgenera is a diagnostics company developing a blood test for the early detection of multiple cancers from a single sample. The test measures circulating microRNA biomarkers using PCR-based methods and applies machine learning to identify signals from up to 12 common cancers before symptoms appear. The company is…
Generative AI and quantum chemistry platform for de novo enzyme design
Xyme is a biotechnology company developing a generative AI and quantum chemistry platform for designing novel enzymes from first principles. Its approach combines computational prediction with experimental validation to create enzymes that catalyse chemical reactions not found in nature. Applications span therapeutic…
AI and photonics platform for personalised drug development
iLoF is a digital health company developing an AI-powered platform that uses proprietary photonics technology to generate optical fingerprints from blood samples, building a cloud-based library of biological profiles and biomarkers. The platform enables non-invasive patient stratification and personalised drug…
Automated chiral chemistry platform for small molecule drug discovery
LCC Technologies is a drug discovery company providing biopharma partners with access to its platform, which combines a proprietary billion-scale virtual chiral library with AI-driven design and automated high-throughput synthesis. The platform delivers stereodefined, sp3-rich building blocks and drug-like compounds…
Cell-specific mRNA delivery platform for genetic medicines
Nuntius Therapeutics is a London-based biotechnology company developing mRNA therapies using proprietary peptide dendrimer and lipid-based nanocarriers designed to deliver genetic payloads to tissues and cell types beyond the liver. The platform combines machine learning-guided carrier design with engineered mRNA…
AI genomics for drug target discovery
OutSee is a genomics and drug discovery company using proprietary AI technology to identify and validate novel therapeutic targets. Its core platform applies predictive algorithms to large-scale genomic datasets to uncover disease-modulating biological mechanisms, complementing traditional analysis methods. OutSee…
AI-powered bioinformatics platform for precision oncology and drug discovery
Rayca Precision develops AI and bioinformatics platforms for precision oncology and drug discovery, using transcriptomic data and deep learning to predict drug responses and stratify cancer patients. The company also provides automated multi-omics analysis for preclinical and clinical research workflows, and works…
AI vision systems for surgical workflows and cell therapy manufacturing
Appraiseye develops AI-powered vision systems for life sciences and healthcare applications across two platforms. Its operating theatre intelligence platform provides real-time instrument tracking, tray utilisation analytics and sterile processing optimisation for surgical departments. Its platform applies AI-guided…